Enhanced Telemedicine for Type 2 Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this pilot clinical trial is to assess feasibility of an intervention to deliver comprehensive, high-quality diabetes care through telemedicine among adults with type 2 diabetes who use insulin and have multiple chronic health conditions. The main question it aims to answer is:Is an enhanced telemedicine intervention for type 2 diabetes compared to usual telemedicine care feasible?Researchers will compare the enhanced telemedicine intervention to usual telemedicine care to see if there are differences in patient satisfaction or preliminary clinical outcomes.Participants will complete 2-3 telemedicine diabetes care visits over approximately 6 months, as well as complete survey measures with each diabetes care visit. Patients in the intervention group will also receive additional support, including pre-visit preparation phone calls, diabetes self-management education and support aligned with their visits, and post-visit follow-up calls.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current medications, especially since the trial involves managing diabetes with insulin.
How is the Enhanced Telemedicine treatment for Type 2 Diabetes different from other treatments?
Enhanced Telemedicine for Type 2 Diabetes is unique because it uses technology to provide real-time support and data sharing between patients and healthcare providers, which can improve glucose control and reduce the need for frequent in-person visits. This approach is particularly beneficial for those who have limited access to traditional healthcare services.12345
What data supports the effectiveness of the treatment Enhanced Telemedicine for Type 2 Diabetes?
Who Is on the Research Team?
Margaret Zupa, MDMS
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for adults with type 2 diabetes who use insulin and have multiple chronic conditions. Participants will engage in telemedicine visits over about 6 months. They must be willing to complete surveys during their care visits.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Baseline survey measures and clinical data collection via chart review
Treatment
Participants receive enhanced telemedicine intervention or usual care for type 2 diabetes
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Telemedicine for Type 2 Diabetes
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator